Description
Tastylia (Tadalafil) 80 mg
Tastylia is a brand name used for tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor. The verified medical information for tadalafil supports use in erectile dysfunction; however, the specific product name “Tastylia 80 mg” is not confirmed by the regulatory sources reviewed, and 80 mg is not a standard tadalafil strength in the official product information checked.
Active Ingredient and Medicine Class
The active ingredient is tadalafil. It belongs to the PDE5 inhibitor class. This medicine class helps increase blood flow to the penis by enhancing the natural erectile response to sexual stimulation.
Established Medical Uses
Official prescribing information for tadalafil includes treatment of erectile dysfunction. In some approved products, tadalafil is also indicated for benign prostatic hyperplasia and for men who have both erectile dysfunction and BPH.
How It Works
Tadalafil inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By preserving cGMP, it supports relaxation of smooth muscle and improves blood flow in erectile tissue during sexual stimulation.
Important Safety Information
Tadalafil must not be used with nitrates because of the risk of a significant drop in blood pressure. Important caution is also required with alpha-blockers and other medicines that can lower blood pressure. It is not appropriate for people with a known hypersensitivity to tadalafil or any tablet component. Regulatory labeling also warns about rare but serious risks such as sudden vision loss, sudden hearing loss, priapism, and cardiovascular events in susceptible patients.
Possible Side Effects
Common adverse effects include headache, flushing, indigestion, nasal congestion, back pain, and muscle pain. Less common but serious reactions can include prolonged erection, severe hypotension, and sudden changes in vision or hearing.
Scientific Evidence
Peer-reviewed clinical reviews and pooled trial analyses show that tadalafil improves erectile function and successful intercourse outcomes compared with placebo in men with erectile dysfunction. Evidence also supports benefit in some men with diabetes and other common causes of erectile dysfunction.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet, prescribing information, or assessment by a qualified healthcare professional.
Medical Sources
- U.S. Food and Drug Administration (FDA) — CIALIS (tadalafil) tablets, for oral use: Highlights of Prescribing Information — FDA prescribing information
- DailyMed — TADALAFIL tablet, film coated — DailyMed label
- Meuleman EJ — Review of tadalafil in the treatment of erectile dysfunction, Expert Opinion on Pharmacotherapy (2003) — PubMed article
